Melanoma prognosis

The prognosis provides information about the outlook after a melanoma diagnosis.

The stage plays an important role in this. In general, the outlook is more favorable if a melanoma is detected at an early stage.

What do the numbers say?

Survival rates are calculated based on large groups of people. They provide a general picture of how many people are still alive five years after diagnosis.

In the Netherlands, the 5-year survival rate is approximately:

– stage I: nearly 100%
– stage II: approximately 80%
– stage III: approximately 75%
– stage IV: approximately 35%

These percentages are averages. They do not predict how the disease will progress in an individual.

What else does the prognosis depend on?

The stage is important, but doctors look at more than that.

Other factors can also play a role, such as:

– how deep the melanoma has grown into the skin
– whether ulceration is present
– whether melanoma cells have been found in lymph nodes
– whether the melanoma has spread further into the body
– which treatment is possible
– the personal health situation

Therefore, two people with the same stage can still have a different course of the disease.

Why do prognosis figures change over time?

Treatments for melanoma have changed in recent years.

Particularly for more advanced melanoma, more treatment options have become available, such as immunotherapy and targeted therapy.

Survival rates therefore always lag slightly behind the latest developments because they are based on people who were treated in previous years.

What is most important to know?

The prognosis provides a general picture, but it is not a personal prediction.

The stage plays an important role, but other characteristics of the melanoma and the treatment also count.

For your own situation, your doctor can best explain which factors are important for you.

Is anything in this explanation still unclear?